|
|
||||||||
Ann Thorac Surg 2007;83:306-308
© 2007 The Society of Thoracic Surgeons
a Departments of Transplantation and Mechanical Circulatory SupportHarefield, Middlesex, United Kingdom
b Department of Pediatric Cardiology, Royal Brompton and Harefield NHS TrustHarefield, Middlesex, United Kingdom
c National Heart and Lung Institute, Harefield, Middlesex, United Kingdom
Accepted for publication March 14, 2006.
* Address correspondence to Dr Birks, Royal Brompton and Harefield NHS Trust, Hill End Rd, Harefield, UB9 6JH Middlesex, UK (Email: e.birks{at}rbhnt.nhs.uk).
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
At 2 years of age our patient had a Mustard procedure for d-TGA using a trouser shaped autologous pericardial patch. Four years later he had surgical repair of superior baffle obstruction followed by balloon dilation of both superior and inferior baffle conduits. He remained well until the age of 15 when he presented with systemic ventricular heart failure. His echocardiogram revealed an estimated ejection fraction of 33%, systolic and diastolic diameters of 46 mm and 55 mm, respectively, and severe tricuspid regurgitation. Cardiac catheterization to assess his baffles status was performed, the results of which are shown in Fig 1. He was added to the transplant waiting list and discharged home while waiting for a donor.
|
A year after implantation his on-off pump echocardiogram (protocol described elsewhere) [1] showed an ejection fraction of 71%; however, off-pump testing did not satisfy our criteria for explantation [2]. Transplantation was performed 1 month later and the donor was a 31-year-old man (body weight, 85 kg). Bypass was established using bi-caval cannulation as far away as possible from the atrium. The heart was removed with the whole of the right atrium and scar tissue as previously described [3]. The donor heart was then inserted using a modified bi-caval anastomosis. The total ischaemic time of the donor heart was 320 minutes and the HeartMate device was explanted from the abdomen.
The patient was discharged home within a few weeks on triple immunosuppressants. He is doing well with an ejection fraction of 65% at 41/2 years since transplantation, and he is employed full time.
| Comment |
|---|
|
|
|---|
Atrial switch operations, namely the Senning and Mustard procedures, described in 1958 and 1964, respectively, are rarely performed today. However there remains a growing population of postoperative patients in their second or third decade of life. The incidence of right ventricular failure ranges from 8% to 44% [4, 5]. The absence of reservoir atrial function with or without baffle obstruction could interfere with the filling and possibly the function of the systemic ventricle leading to severe elevation of pulmonary venous pressure, which can result in progressive pulmonary vascular disease.
The patient required one invasive operation and transcutaneous balloon dilation of both baffles after his initial Mustard procedure for baffle obstruction. At the age of 15 he presented with severe heart failure refractory to medical management. The poor function and dilatation of the systemic ventricle resulted in compromise of his pulmonary ventricle leading to severe low cardiac output [6].
Other measures such as tricuspid repair or performing two-stage anatomical correction were considered to be nonviable options because of the advanced functional and structural changes of both ventricles.
Implantation of the left ventricular assist device in children or adults with congenital heart disease is not very common, and certainly the use of left ventricular assist devices in patients after atrial repair of TGA poses specific problems. Author Under and colleagues [7] reported that 3 of their 17 patients requiring extracorporeal life support had TGA. The only patient who was implanted with the HeartMate I had congenitally corrected TGA and died 106 days post-implantation.
The shape and size of the inflow cannula of the HeartMate I is designed for the left ventricle. The apex of the right ventricle is not as well developed and does not correspond to the apex of the heart. It also contains many trabeculae that could disturb the flow to the inflow cannula leading to inadequate drainage. These anatomical differences require special attention in placing the inflow cannula in the right ventricle to guarantee unobstructed flow in and out of the device, avoid injury to the liver and gut, and importantly to allow the chest to be closed.
Positioning of the device was addressed by Wiklund and colleagues [8] when they rotated the HeartMate I device back-to-front with the inflow to the right and the outflow cannula to the left in a patient with severe heart failure after a failing Mustard procedure [8]. They aimed to achieve optimal drainage with minimal disruption to the inflow or compromise to other organs. In our case this was unnecessary, and just placement of the device nearer to the midline was enough to achieve optimal drainage without any compromise to other organs, specifically the liver.
Explantation of the device from the peritoneal cavity was facilitated both by the absence of adhesions to the body of the device, and the fact that the Dacron velour (Thoratec Corp., Pleasanton, CA) covers part of the drive line excluding it from the peritoneal cavity during insertion.
Insertion of a left ventricular assist device in patients with congenital cardiac defects and those who had them repaired is technically demanding and time consuming. We show that insertion of a left ventricular assist device into the right ventricle of a patient with surgically corrected d-TGA is feasible and it served two purposes. First, it mechanically unloaded the systemic ventricle, thus reducing pulmonary hypertension that could have induced right heart failure in the transplanted heart, and second, the device acted as a bridge to transplantation. It is hoped that this report will help in optimizing the management of these patients.
| References |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |